{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:22:55Z","timestamp":1794640975399,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grant","doi-asserted-by":"crossref","award":["81671598"],"award-info":[{"award-number":["81671598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grant","doi-asserted-by":"crossref","award":["81801601"],"award-info":[{"award-number":["81801601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai grant","award":["20ZR1451400"],"award-info":[{"award-number":["20ZR1451400"]}]},{"name":"Clinical research program of Tongji Hospital Tongji University","award":["ITJZD1909"],"award-info":[{"award-number":["ITJZD1909"]}]},{"name":"Science and technology commission of Shanghai","award":["20Y11911600"],"award-info":[{"award-number":["20Y11911600"]}]},{"name":"Shanghai Sailing Program","award":["17YF1417200"],"award-info":[{"award-number":["17YF1417200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To identify primary Sj\u00f6gren\u2019<jats:italic>s<\/jats:italic> syndrome (pSS) patients with arthralgia at risk for osteoarthritis (OA) or arthritis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 368 pSS patients admitted to a mono-centric from March 2010 to December 2020. Patients were divided into groups according to whether complicated with OA or arthritis. Data were analyzed to determine the differences in demographical characteristics, symptoms, and laboratory examination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The involvement of the OA joints was predominately knee and spine sites (including cervical and lumbar spine degeneration). When diagnosing arthritis, it was mainly peripheral symmetric polyarthritis, the most affected sites were the interphalangeal and metacarpophalangeal joints. There were significant differences in age, disease duration, uric acid (UA), and total cholesterol (TC) between pSS-OA and pSS-nOA patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.050). Logistic regression analysis showed that age (OR\u2009=\u20091.965; <jats:italic>P<\/jats:italic>\u2009=\u20090.009) and joint pain (OR\u2009=\u20093.382; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) were dangerous factors associated with OA. Interestingly, although the level of UA, TC, and triglycerides (TG) was shown to be positive with OA, there was no statistical significance after the OR was computed in the four-cell table. In pSS-arthritis, EULAR Sj\u00f6gren'<jats:italic>s<\/jats:italic> syndrome disease activity index (ESSDAI) (<jats:italic>P<\/jats:italic>\u2009=\u20090.011), the frequency of joint pain (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and muscular involvement (<jats:italic>P<\/jats:italic>\u2009=\u20090.037) were higher than non-arthritis group. In pSS patients only presenting with joint pain, arthritis patients had higher ESSDAI and system involvements, but lower UA and TG levels compared with OA group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.050).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In pSS patients with arthralgia, OA accounted for the majority. pSS patients with advanced age and more pronounced metabolic characteristics, such as elevated blood lipids and uric acid, was a key factor in groups at risk for OA. However, arthritis patients had higher rates of dry mouth and eye, higher disease activity, antibodies positive, and more organs damage. In the future, it may be necessary to be more cautious in the diagnosis of joint manifestations in pSS patients in order to make the appropriate treatments.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03513-1","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T08:03:04Z","timestamp":1673856184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Osteoarthritis or arthritis? Toward understanding of primary Sj\u00f6gren\u2019s syndrome patients with arthralgia"],"prefix":"10.1186","volume":"18","author":[{"given":"Ronglin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"issue":"10","key":"3513_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMcp1702514","volume":"378","author":"X Mariette","year":"2018","unstructured":"Mariette X, Criswell LA. Primary Sj\u00f6gren\u2019s syndrome. N Engl J Med. 2018;378(10):931\u20139. https:\/\/doi.org\/10.1056\/NEJMcp1702514.","journal-title":"N Engl J Med"},{"issue":"7","key":"3513_CR2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.3390\/jcm9072299","volume":"9","author":"D Parisis","year":"2020","unstructured":"Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current state of knowledge on primary Sj\u00f6gren\u2019s syndrome, an autoimmune exocrinopathy. J Clin Med. 2020;9(7):2299. https:\/\/doi.org\/10.3390\/jcm9072299.","journal-title":"J Clin Med"},{"issue":"3","key":"3513_CR3","first-page":"97","volume":"118","author":"S Retamozo","year":"2019","unstructured":"Retamozo S, Acar-Denizli N, Rasmussen A, Horv\u00e1th IF, Baldini C, Priori R, et al. Systemic manifestations of primary Sj\u00f6gren\u2019s syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients. Clin Exp Rheumatol. 2019;118(3):97\u2013106.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"3513_CR4","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1093\/rheumatology\/keab939","volume":"61","author":"LG Chatzis","year":"2022","unstructured":"Chatzis LG, Stergiou IE, Goules AV, Pezoulas V, Tsourouflis G, Fotiadis D, Tzioufas AG, Voulgarelis M. Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021). Rheumatology (Oxford). 2022;61(9):3576\u201385. https:\/\/doi.org\/10.1093\/rheumatology\/keab939.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3513_CR5","first-page":"88","volume":"25","author":"HJ Haga","year":"2007","unstructured":"Haga HJ, Peen E. A study of the arthritis pattern in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2007;25(1):88\u201391.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3513_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10067-016-3175-3","volume":"35","author":"EJ ter Borg","year":"2016","unstructured":"ter Borg EJ, Kelder JC. Polyarthritis in primary Sj\u00f6gren\u2019s syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up. Clin Rheumatol. 2016;35(3):649\u201355. https:\/\/doi.org\/10.1007\/s10067-016-3175-3.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"3513_CR7","first-page":"485","volume":"10","author":"A Castro-Poltronieri","year":"1983","unstructured":"Castro-Poltronieri A, Alarc\u00f3n-Segovia D. Articular manifestations of primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 1983;10(3):485\u20138.","journal-title":"J Rheumatol"},{"issue":"1","key":"3513_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.berh.2015.05.002","volume":"29","author":"C Vitali","year":"2015","unstructured":"Vitali C, Del Papa N. Pain in primary Sj\u00f6gren\u2019s syndrome. Best Pract Res Clin Rheumatol. 2015;29(1):63\u201370. https:\/\/doi.org\/10.1016\/j.berh.2015.05.002.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"3513_CR9","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/rheumatology\/keq047","volume":"49","author":"AL Fauchais","year":"2010","unstructured":"Fauchais AL, Ouattara B, Gondran G, Lallou\u00e9 F, Petit D, Ly K, et al. Articular manifestations in primary Sj\u00f6gren\u2019s syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford). 2010;49(6):1164\u201372. https:\/\/doi.org\/10.1093\/rheumatology\/keq047.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"3513_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/ard.2004.029066","volume":"64","author":"MN Lazarus","year":"2005","unstructured":"Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2005;64(7):1062\u20134. https:\/\/doi.org\/10.1136\/ard.2004.029066.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3513_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","volume":"18","author":"A Mirouse","year":"2019","unstructured":"Mirouse A, Seror R, Vicaut E, Mariette X, Dougados M, Fauchais AL, et al. Arthritis in primary Sj\u00f6gren\u2019s syndrome: characteristics, outcome and treatment from French multicenter retrospective study. Autoimmun Rev. 2019;18(1):9\u201314. https:\/\/doi.org\/10.1016\/j.autrev.2018.06.015.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"3513_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2019-216515","volume":"79","author":"S Safiri","year":"2020","unstructured":"Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of osteoarthritis 1990\u20132017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216515.","journal-title":"Ann Rheum Dis"},{"issue":"10264","key":"3513_CR13","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(20)32230-3","volume":"396","author":"DJ Hunter","year":"2020","unstructured":"Hunter DJ, March L, Chew M. Osteoarthritis in 2020 and beyond: a lancet commission. Lancet. 2020;396(10264):1711\u20132. https:\/\/doi.org\/10.1016\/S0140-6736(20)32230-3.","journal-title":"Lancet"},{"issue":"2","key":"3513_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/BOR.0000000000000479","volume":"30","author":"ER Vina","year":"2018","unstructured":"Vina ER, Kwoh CK. Epidemiology of osteoarthritis: literature update. Curr Opin Rheumatol. 2018;30(2):160\u20137. https:\/\/doi.org\/10.1097\/BOR.0000000000000479.","journal-title":"Curr Opin Rheumatol"},{"issue":"9991","key":"3513_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ. Osteoarthritis. Lancet. 2015;386(9991):376\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(14)60802-3.","journal-title":"Lancet"},{"issue":"2","key":"3513_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.joca.2021.04.020","volume":"30","author":"KD Allen","year":"2022","unstructured":"Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthr Cartil. 2022;30(2):184\u201395. https:\/\/doi.org\/10.1016\/j.joca.2021.04.020.","journal-title":"Osteoarthr Cartil"},{"issue":"7","key":"3513_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fmed.2020.00392","volume":"10","author":"YH Lee","year":"2020","unstructured":"Lee YH, Tsou HK, Kao SL, Gau SY, Bai YC, Lin MC, et al. Patients with rheumatoid arthritis increased risk of developing osteoarthritis: a nationwide population-based cohort study in Taiwan. Front Med (Lausanne). 2020;10(7):392. https:\/\/doi.org\/10.3389\/fmed.2020.00392.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3513_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-019-04639-6","volume":"39","author":"K Sakata","year":"2020","unstructured":"Sakata K, Kaneko Y, Yasuoka H, Takeuchi T. Association of radiographic findings in hand X-ray with clinical features and autoantibodies in patients with systemic sclerosis. Clin Rheumatol. 2020;39(1):113\u20138. https:\/\/doi.org\/10.1007\/s10067-019-04639-6.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3513_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/ard.41.2.147","volume":"41","author":"M Baron","year":"1982","unstructured":"Baron M, Lee P, Keystone EC. The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1982;41(2):147\u201352. https:\/\/doi.org\/10.1136\/ard.41.2.147.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3513_CR20","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3899\/jrheum.150841","volume":"43","author":"A Aksoy","year":"2016","unstructured":"Aksoy A, Solmaz D, Can G, Cetin P, Balci A, Akar S, et al. Increased frequency of hand osteoarthritis in patients with primary Sj\u00f6gren syndrome compared with systemic lupus erythematosus. J Rheumatol. 2016;43(6):1068\u201371. https:\/\/doi.org\/10.3899\/jrheum.150841.","journal-title":"J Rheumatol"},{"issue":"6","key":"3513_CR21","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138. https:\/\/doi.org\/10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3513_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859.","journal-title":"Arthritis Rheumatol"},{"key":"3513_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3760\/cma.j.issn.0253-2352.2018.12.001","volume":"38","author":"Joint Surgery Group","year":"2018","unstructured":"Joint Surgery Group. Chinese Orthopaedics Association Osteoarthritis diagnosis and treatment guideline (2018). Chin J Orthop. 2018;38:705\u201315. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2352.2018.12.001.","journal-title":"Chin J Orthop."},{"issue":"6","key":"3513_CR24","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2010;69(6):1103\u20139. https:\/\/doi.org\/10.1136\/ard.2009.110619.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"3513_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2011;70(6):968\u201372. https:\/\/doi.org\/10.1136\/ard.2010.143743.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3513_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/acr.21898","volume":"65","author":"E Losina","year":"2013","unstructured":"Losina E, Weinstein AM, Reichmann WM, Burbine SA, Solomon DH, Daigle ME, et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken). 2013;65(5):703\u201311. https:\/\/doi.org\/10.1002\/acr.21898.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"3513_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41584-020-00533-7","volume":"17","author":"PR Coryell","year":"2021","unstructured":"Coryell PR, Diekman BO, Loeser RF. Mechanisms and therapeutic implications of cellular senescence in osteoarthritis. Nat Rev Rheumatol. 2021;17(1):47\u201357. https:\/\/doi.org\/10.1038\/s41584-020-00533-7.","journal-title":"Nat Rev Rheumatol"},{"key":"3513_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.mad.2019.03.003","volume":"180","author":"MS O'Brien","year":"2019","unstructured":"O\u2019Brien MS, McDougall JJ. Age and frailty as risk factors for the development of osteoarthritis. Mech Ageing Dev. 2019;180:21\u20138. https:\/\/doi.org\/10.1016\/j.mad.2019.03.003.","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"3513_CR29","doi-asserted-by":"publisher","first-page":"9739","DOI":"10.1038\/s41598-017-10158-8","volume":"7","author":"M Zhou","year":"2017","unstructured":"Zhou M, Guo Y, Wang D, Shi D, Li W, Liu Y, Yuan J, He M, Zhang X, Guo H, Wu T, Chen W. The cross-sectional and longitudinal effect of hyperlipidemia on knee osteoarthritis: results from the Dongfeng-Tongji cohort in China. Sci Rep. 2017;7(1):9739. https:\/\/doi.org\/10.1038\/s41598-017-10158-8.","journal-title":"Sci Rep"},{"issue":"9","key":"3513_CR30","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.joca.2019.05.013","volume":"27","author":"S Wang","year":"2019","unstructured":"Wang S, Pillinger MH, Krasnokutsky S, Barbour KE. The association between asymptomatic hyperuricemia and knee osteoarthritis: data from the third National Health and Nutrition Examination Survey. Osteoarthr Cartil. 2019;27(9):1301\u20138. https:\/\/doi.org\/10.1016\/j.joca.2019.05.013.","journal-title":"Osteoarthr Cartil"},{"key":"3513_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101249","volume":"66","author":"L Zheng","year":"2021","unstructured":"Zheng L, Zhang Z, Sheng P, Mobasheri A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res Rev. 2021;66: 101249.","journal-title":"Ageing Res Rev"},{"issue":"1\u20132","key":"3513_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cca.2011.10.019","volume":"413","author":"F Oliviero","year":"2012","unstructured":"Oliviero F, Lo Nigro A, Bernardi D, Giunco S, Baldo G, Scanu A, Sfriso P, Ramonda R, Plebani M, Punzi L. A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides. Clin Chim Acta. 2012;413(1\u20132):303\u20137. https:\/\/doi.org\/10.1016\/j.cca.2011.10.019.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"3513_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/1756-185X.13061","volume":"20","author":"S Farnaghi","year":"2017","unstructured":"Farnaghi S, Crawford R, Xiao Y, Prasadam I. Cholesterol metabolism in pathogenesis of osteoarthritis disease. Int J Rheum Dis. 2017;20(2):131\u201340.","journal-title":"Int J Rheum Dis"},{"issue":"7293","key":"3513_CR34","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357\u201361. https:\/\/doi.org\/10.1038\/nature08938.","journal-title":"Nature"},{"issue":"1","key":"3513_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","volume":"21","author":"F Berenbaum","year":"2013","unstructured":"Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr Cartil. 2013;21(1):16\u201321. https:\/\/doi.org\/10.1016\/j.joca.2012.11.012.","journal-title":"Osteoarthr Cartil"},{"issue":"5","key":"3513_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14728220902915310","volume":"13","author":"I Takada","year":"2009","unstructured":"Takada I, Kouzmenko AP, Kato S. Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opin Ther Targets. 2009;13(5):593\u2013603.","journal-title":"Expert Opin Ther Targets"},{"issue":"11","key":"3513_CR37","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00296-018-4141-y","volume":"38","author":"SK Kim","year":"2018","unstructured":"Kim SK, Kwak SG, Choe JY. Serum uric acid level is not associated with osteoarthritis in Korean population: data from the Seventh Korea National Health and Nutrition Examination Survey 2016. Rheumatol Int. 2018;38(11):2077\u201385. https:\/\/doi.org\/10.1007\/s00296-018-4141-y.","journal-title":"Rheumatol Int"},{"issue":"6","key":"3513_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/art.40069","volume":"69","author":"S Krasnokutsky","year":"2017","unstructured":"Krasnokutsky S, Oshinsky C, Attur M, Ma S, Zhou H, Zheng F, Chen M, Patel J, Samuels J, Pike VC, Regatte R, Bencardino J, Rybak L, Abramson S, Pillinger MH. Serum urate levels predict joint space narrowing in non-gout patients with medial knee osteoarthritis. Arthritis Rheumatol. 2017;69(6):1213\u201320. https:\/\/doi.org\/10.1002\/art.40069.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"3513_CR39","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1093\/rheumatology\/keab048","volume":"60","author":"DJ Go","year":"2021","unstructured":"Go DJ, Kim DH, Kim JY, Guermazi A, Crema MD, Hunter DJ, Kim HA. Serum uric acid and knee osteoarthritis in community residents without gout: a longitudinal study. Rheumatology (Oxford). 2021;60(10):4581\u201390. https:\/\/doi.org\/10.1093\/rheumatology\/keab048.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3513_CR40","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.jbspin.2018.11.002","volume":"86","author":"T Neogi","year":"2019","unstructured":"Neogi T, Krasnokutsky S, Pillinger MH. Urate and osteoarthritis: evidence for a reciprocal relationship. Joint Bone Spine. 2019;86(5):576\u201382. https:\/\/doi.org\/10.1016\/j.jbspin.2018.11.002.","journal-title":"Joint Bone Spine"},{"issue":"7081","key":"3513_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341. https:\/\/doi.org\/10.1038\/nature04516.","journal-title":"Nature"},{"issue":"5","key":"3513_CR42","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1073\/pnas.1012743108","volume":"108","author":"AE Denoble","year":"2011","unstructured":"Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, Coleman RE, Kraus VB. Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A. 2011;108(5):2088\u201393. https:\/\/doi.org\/10.1073\/pnas.1012743108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3513_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.semarthrit.2010.07.006","volume":"40","author":"EJ ter Borg","year":"2011","unstructured":"ter Borg EJ, Risselada AP, Kelder JC. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum. 2011;40(6):547\u201351. https:\/\/doi.org\/10.1016\/j.semarthrit.2010.07.006.","journal-title":"Semin Arthritis Rheum"},{"issue":"11","key":"3513_CR44","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1007\/s10067-017-3822-3","volume":"36","author":"J Demarchi","year":"2017","unstructured":"Demarchi J, Papasidero S, Medina MA, Klajn D, Chaparro Del Moral R, Rillo O, Martir\u00e9 V, Crespo G, Secco A, Catalan Pellet A, Amitrano C, Crow C, Asnal C, Pucci P, Caeiro F, Benzanquen N, Pirola JP, Mayer M, Zazzetti F, Velez S, Barreira J, Tamborenea N, Santiago L, Raiti L. Primary Sj\u00f6gren\u2019s syndrome: extraglandular manifestations and hydroxychloroquine therapy. Clin Rheumatol. 2017;36(11):2455\u201360. https:\/\/doi.org\/10.1007\/s10067-017-3822-3.","journal-title":"Clin Rheumatol"},{"issue":"9","key":"3513_CR45","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1007\/s10067-016-3360-4","volume":"35","author":"C Kedor","year":"2016","unstructured":"Kedor C, Zernicke J, Hagemann A, Gamboa LM, Callhoff J, Burmester GR, Feist E. A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 2016;35(9):2203\u201310. https:\/\/doi.org\/10.1007\/s10067-016-3360-4.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3513_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/acr.24131","volume":"72","author":"SL Kolasinski","year":"2020","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care Res (Hoboken). 2020;72(2):149\u201362. https:\/\/doi.org\/10.1002\/acr.24131.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"3513_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","volume":"51","author":"S Ferrero","year":"2021","unstructured":"Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V, Ziegler L, Kremer J, Loeuille D, Roux CH. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021;51(4):831\u20138. https:\/\/doi.org\/10.1016\/j.semarthrit.2021.04.016.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03513-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T08:06:55Z","timestamp":1673856415000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03513-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3513"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03513-1","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was in accordance with the standards of the ethical review board of Shanghai Tongji Hospital and with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}